Peripheral blood stem cell mobilization in multiple myeloma (MM): High-dose cyclophosphamide plus G-CSF vs. G-CSF alone

被引：0
|
作者：
Goldschmidt, H [1 ]
Hegenbart, U [1 ]
Cremer, FW [1 ]
Kiel, K [1 ]
Moos, M [1 ]
机构：
[1] Univ Heidelberg, Dept Internal Med 5, Heidelberg, Germany
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 1998年 / 102卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：72 / 72
页数：1
相关论文
共 50 条
  • [31] Stem Cell Mobilization With Plerixafor plus G-CSF In Comparison To Cyclophosphamide plus G-CSF and Time-To-Progression After Autologous Stem Cell Transplantation For Multiple Myeloma
    Garfall, Alfred L.
    Dougherty, Andrew
    Vogl, Dan T.
    Weiss, Brendan M.
    Cohen, Adam D.
    Porter, David L.
    O'Doherty, Una
    Mangan, Patricia
    Cunningham, Kathleen
    Siegel, Don L.
    Stadtmauer, Edward A.
    BLOOD, 2013, 122 (21)
  • [32] MOBILIZATION OF HEMATOPOIETIC PROGENITOR CELLS WITH HIGH-DOSE CYCLOPHOSPHAMIDE AND G-CSF IN PATIENTS WITH MULTIPLE MYELOMA
    Fernandez-Luis, S.
    Gomez Lamas, D.
    Calvo Sanchez, J. A.
    Fernandez Garcia, S.
    Fernandez Martinez, S.
    Mora Barrios, J.
    Gonzalez Romero, Y.
    Sanchez Escamilla, M.
    Cabero Martinez, A.
    Yanez San Segundo, L.
    Amunarriz Agueda, C.
    Insunza Gaminde, A.
    Ocio San Miguel, E. M.
    Bermudez Rodriguez, A.
    HAEMATOLOGICA, 2019, 104 : 318 - 319
  • [33] Comparison of the efficiency, safety, and survival outcomes in two stem cell mobilization regimens with cyclophosphamide plus G-CSF or G-CSF alone in multiple myeloma: a meta-analysis
    Liwen Wang
    Hongxian Xiang
    Yuhan Yan
    Zuqun Deng
    Hui Li
    Xin Li
    Jing Liu
    Annals of Hematology, 2021, 100 : 563 - 573
  • [34] Selection of a mobilization regimen for multiple myeloma based on the response to induction therapy: granulocyte-colony stimulating factor (G-CSF) alone versus high-dose cyclophosphamide plus G-CSF
    Jang, Ji Eun
    Cheong, June-Won
    Kim, Soo-Jeong
    Cho, Hyunsoo
    Suh, Cheolwon
    Lee, Hyewon
    Eom, Hyeon-Seok
    Yhim, Ho-Young
    Lee, Won-Sik
    Min, Chang-Ki
    Lee, Jae Hoon
    Park, Joon Seong
    Kim, Jin Seok
    LEUKEMIA & LYMPHOMA, 2016, 57 (06) : 1389 - 1397
  • [35] EFFICACY OF BIOSIMILAR G-CSF VERSUS ORIGINATOR G-CSF IN PERIPHERAL BLOOD STEM CELL MOBILIZATION IN de novo MULTIPLE MYELOMA PATIENTS
    Moscato, T.
    Recchia, A. G.
    Fedele, R.
    Neri, S.
    Gentile, M.
    Alati, C.
    Vincelli, I. O.
    Piro, E.
    Penna, G.
    Musolino, C.
    Ronco, F.
    Molica, S.
    Morabito, F.
    Martino, M.
    HAEMATOLOGICA, 2015, 100 : 32 - 32
  • [36] ESHAP plus G-CSF as an effective peripheral blood progenitor cell mobilization regimen in pretreated non-Hodgkin's lymphoma: comparison with high-dose cyclophosphamide plus G-CSF
    J-L Lee
    S Kim
    S W Kim
    E-K Kim
    S-B Kim
    Y-K Kang
    J Lee
    M W Kim
    C J Park
    H-S Chi
    J Huh
    S-H Kim
    C Suh
    Bone Marrow Transplantation, 2005, 35 : 449 - 454
  • [37] High-Dose Cyclophosphamide In Combination With G-CSF Versus G-CSF Alone For Mobilization Of Hematopoietic Stem Cells After Induction Therapy Including Velcade, Cyclophosphamide and Dexacort
    Benyamini, Noam
    Avivi, Irit
    Dann, Eldad J.
    Zuckerman, Tsila
    Noa, Lavi
    Katz, Tami
    BLOOD, 2013, 122 (21)
  • [38] ESHAP plus G-CSF as an effective peripheral blood progenitor cell mobilization regimen in pretreated non-Hodgkin's lymphoma: comparison with high-dose cyclophosphamide plus G-CSF
    Lee, JL
    Kim, S
    Kim, SW
    Kim, EK
    Kim, SB
    Kang, YK
    Lee, J
    Kim, MW
    Park, CJ
    Chi, HS
    Huh, J
    Kim, SH
    Suh, C
    BONE MARROW TRANSPLANTATION, 2005, 35 (05) : 449 - 454
  • [39] Use of concurrent G-CSF + GM-CSF vs G-CSF alone for mobilization of peripheral blood stem cells in children with malignant disease
    L Madero
    M González-Vicent
    J Molina
    R Madero
    V Quintero
    MA Díaz
    Bone Marrow Transplantation, 2000, 26 : 365 - 369
  • [40] Outcomes of G-CSF alone vs G-CSF with upfront plerixafor vs G-CSF/chemotherapy for collection of autologous stem cells in patients with multiple myeloma.
    Talamo, Giampaolo
    George, Melissa
    Ehmann, W. Christopher
    Drabick, Joseph J.
    Mineishi, Shin
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
12345